DK1474422T3 - R-(-)-1-[2-(7-chlorbenzo[b]thiophen-3-ylmethoxy)-2-(2,4-dichlorphenyl)ethyl]-1H imidazol - Google Patents

R-(-)-1-[2-(7-chlorbenzo[b]thiophen-3-ylmethoxy)-2-(2,4-dichlorphenyl)ethyl]-1H imidazol

Info

Publication number
DK1474422T3
DK1474422T3 DK03702597T DK03702597T DK1474422T3 DK 1474422 T3 DK1474422 T3 DK 1474422T3 DK 03702597 T DK03702597 T DK 03702597T DK 03702597 T DK03702597 T DK 03702597T DK 1474422 T3 DK1474422 T3 DK 1474422T3
Authority
DK
Denmark
Prior art keywords
thiophen
imidazole
ethyl
chlorobenzo
ylmethoxy
Prior art date
Application number
DK03702597T
Other languages
Danish (da)
English (en)
Inventor
Rafael Foguet
Celia Palacin
Luis Anglada
Antonio Guglietta
Jorge Ramentol
Original Assignee
Ferrer Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferrer Int filed Critical Ferrer Int
Application granted granted Critical
Publication of DK1474422T3 publication Critical patent/DK1474422T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
DK03702597T 2002-02-11 2003-02-04 R-(-)-1-[2-(7-chlorbenzo[b]thiophen-3-ylmethoxy)-2-(2,4-dichlorphenyl)ethyl]-1H imidazol DK1474422T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES200200328A ES2203316B1 (es) 2002-02-11 2002-02-11 R-(-)-1-(2-(7-cloro-benzo(b)tiofen-3-il-metoxi)-2-(2,4-dicloro-fenil)-etil)1h-imidazol.
PCT/EP2003/001089 WO2003068770A1 (fr) 2002-02-11 2003-02-04 R-(-)-1-[2-(7-chlorobenzo[b]thiophen-3-yl-methoxy)-2-(2,4-dichlorophenyl)-ethyl]-1h-imidazoles

Publications (1)

Publication Number Publication Date
DK1474422T3 true DK1474422T3 (da) 2008-05-13

Family

ID=27675919

Family Applications (1)

Application Number Title Priority Date Filing Date
DK03702597T DK1474422T3 (da) 2002-02-11 2003-02-04 R-(-)-1-[2-(7-chlorbenzo[b]thiophen-3-ylmethoxy)-2-(2,4-dichlorphenyl)ethyl]-1H imidazol

Country Status (25)

Country Link
US (1) US7323433B2 (fr)
EP (1) EP1474422B1 (fr)
JP (1) JP5095070B2 (fr)
KR (1) KR100701457B1 (fr)
CN (1) CN1315824C (fr)
AT (1) ATE382618T1 (fr)
AU (1) AU2003205733B8 (fr)
BR (1) BR0307754A (fr)
CA (1) CA2474627C (fr)
CO (1) CO5601026A2 (fr)
DE (1) DE60318395T2 (fr)
DK (1) DK1474422T3 (fr)
ES (1) ES2203316B1 (fr)
HK (1) HK1070883A1 (fr)
IL (1) IL163452A (fr)
MX (1) MXPA04007581A (fr)
NO (1) NO327937B1 (fr)
NZ (1) NZ534464A (fr)
PL (1) PL211168B1 (fr)
PT (1) PT1474422E (fr)
RU (1) RU2276152C1 (fr)
TN (1) TNSN04140A1 (fr)
UA (1) UA78010C2 (fr)
WO (1) WO2003068770A1 (fr)
ZA (1) ZA200405941B (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2249991B1 (es) * 2004-09-13 2007-03-01 Ferrer Internacional, S.A. Procedimiento de fabricacion de compuestos imidazolicos, sus sales y sus pseudopolimorfos.
ES2249992B1 (es) 2004-09-13 2007-03-01 Ferrer Internacional, S.A. Un procedimiento para fabricar compuestos enantiomericos del imidazol.
EP1698336A1 (fr) * 2005-03-01 2006-09-06 Ferrer Internacional, S.A. Compositions antifongiques comprenant le sertaconazole ainsi que l' hydrocortisone ou un agent antibactérien
AU2009326091A1 (en) 2008-12-09 2010-06-17 Ferrer Internacional, S.A. Polymorph II of an antifungal compound
EP2436374A1 (fr) * 2010-09-30 2012-04-04 Ferrer Internacional, S.A. Ovule pour l'administration vaginale d'arasertaconazole
EP2551351A1 (fr) 2011-07-29 2013-01-30 Interquim, S.A. Procédé de préparation du (R)-(-)-1-(2,4-dichloro-phényl)-2-imidazole-1-yl-éthanol optiquement actif
CN102440947B (zh) * 2011-11-15 2012-12-26 海南海神同洲制药有限公司 硝酸舍他康唑乳膏剂
KR101717968B1 (ko) 2016-07-18 2017-03-20 씨앤아이 주식회사 스마트폰 결합 모듈
CN113480517B (zh) * 2021-07-30 2022-09-09 海南海神同洲制药有限公司 3-溴甲基-7-氯苯并[b]噻吩的合成方法
CN113735843B (zh) * 2021-09-07 2023-05-26 海南海神同洲制药有限公司 一种低熔点硝酸舍他康唑的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1250586A (fr) * 1984-02-02 1989-02-28 Manuel Raga Derives de 1h-imidazole et procede de production
US5135943A (en) * 1984-02-02 1992-08-04 Ferrer Internacional S.A. 1H-imidazole derivative compounds and pharmaceutical compositions containing the same
US5087620A (en) * 1990-05-17 1992-02-11 Bristol-Myers Squibb Co. Controlled dermal penetration enhancement using imidazoles
DE69503364T2 (de) * 1995-01-04 1999-04-15 Ferrer Internacional S.A., Barcelona Verfahren zur herstellung von polymorphe b und c von 1-(2,4-dichloro-beta-((7-chloro-benzo(b)thien-3-yl)methoxy)phenethyl) imidazol-mononitrat

Also Published As

Publication number Publication date
CN1630654A (zh) 2005-06-22
EP1474422B1 (fr) 2008-01-02
US20050065201A1 (en) 2005-03-24
NZ534464A (en) 2006-02-24
KR20040079996A (ko) 2004-09-16
ES2203316A1 (es) 2004-04-01
CA2474627C (fr) 2009-09-22
KR100701457B1 (ko) 2007-03-29
MXPA04007581A (es) 2004-11-10
PL370251A1 (en) 2005-05-16
CN1315824C (zh) 2007-05-16
IL163452A (en) 2011-11-30
AU2003205733A1 (en) 2003-09-04
ES2203316B1 (es) 2005-03-01
NO327937B1 (no) 2009-10-26
WO2003068770A1 (fr) 2003-08-21
RU2276152C1 (ru) 2006-05-10
PT1474422E (pt) 2008-02-28
PL211168B1 (pl) 2012-04-30
BR0307754A (pt) 2004-12-07
CA2474627A1 (fr) 2003-08-21
HK1070883A1 (en) 2005-06-30
ATE382618T1 (de) 2008-01-15
JP2005524639A (ja) 2005-08-18
ZA200405941B (en) 2006-07-26
JP5095070B2 (ja) 2012-12-12
RU2004127573A (ru) 2006-02-10
US7323433B2 (en) 2008-01-29
UA78010C2 (uk) 2007-02-15
DE60318395T2 (de) 2009-01-02
EP1474422A1 (fr) 2004-11-10
AU2003205733B8 (en) 2008-09-04
DE60318395D1 (de) 2008-02-14
NO20043377L (no) 2004-08-13
CO5601026A2 (es) 2006-01-31
TNSN04140A1 (en) 2007-03-12
AU2003205733B2 (en) 2008-08-14

Similar Documents

Publication Publication Date Title
HK1070883A1 (en) R-(-)-1-2-(7-chlorobenzo-b-thiophen-3-yl-methoxy)-2(2,4-dichlorophenyl)ethyl-1h-imidazole
PH12020551682A1 (en) N-(cyclopropylmethyl)-5-(methylsulfonyl)-n-{1-[1-(pyrimidin-2-yl)-1h-1,2,4-triazol-5-yl]ethyl}benzamide derivatives and the corresponding pyridine-carboxamide derivatives as pesticides
PH12019501835A1 (en) Composition for controlling harmful microorganisms comprising 1 - (phenoxy-pyridinyl) -2- (1,2,4-triazol-1 -yl)-ethanol derivatives
WO2004016086A3 (fr) Imidazoles 2,4,5-trisubstitues et utilisation de ceux-ci comme agents anti-microbiens
RS20060173A (en) Use of fungicides for disinfecting cereal seed
HUP0203563A2 (hu) Fungicid hatású, aktív vegyületkombináció és alkalmazása
WO2005030753A3 (fr) Agents therapeutiques utiles pour traiter la douleur
HUP9901550A2 (hu) Növényimmunizáló hatású benzotiadiazolszármazékot tartalmazó szinergetikus fungicid készítmények és alkalmazásuk
EA003136B1 (ru) Синергетические фунгицидные смеси на основе производных n-фенилникотинамида и азолов
PT884997E (pt) Composicoes contendo um fungicida e um composto sulfurado
WO2001066551A3 (fr) Composes azole comme agents therapeutiques pour traiter des infections mycosiques
EA201891044A1 (ru) Комбинации активных соединений, содержащие производное (тио)карбоксамида и фунгицидное соединение
AU2018285656A1 (en) Stabilised formulations containing prothioconazole with a low 2-(1-chlorocyclopropyl)-1-(2-chlorophenyl)-3-(1H-1,2,4-triazol-1-yl)propan-2-ol content
AR001834A1 (es) Empleo de una combinación de productos activos en la fabricación del cuero agente microbicida que contiene dichos productos activos procedimiento parala protección de pieles animales y del cuero cont ra el ataque microbiano empleo de dicha combinación para la obtención de agentes
EA200100586A1 (ru) Применение производных фосфономуравьиной кислоты для лечения инфекций
AR002150A1 (es) Composiciones fungicidas que contienen 8-t-butil-2-(n-etil-n-n-propilamino) -metil-1,4-dioxaespiro[5,4] decano, tebuconazol y propiconazol, procedimientopara la obtencion de dichas composiciones y procedimientos para la lucha contra hongos.
WO2002080669A3 (fr) Utilisation d'agonistes des recepteurs $g(a)2-adrenergiques et d'inhibiteurs adrenergiques pour reduire la defoliation
WO2002055022A3 (fr) Metabolite actif de compose antifongique
AR026545A1 (es) Combinaciones de productos activos fungicidas
MX2021011359A (es) Formulaciones estabilizadas de tiocetonas.
WO2003007878A3 (fr) Agents antifongiques de derives de sordarine
ATE238050T1 (de) 4-cyano-4-deformylsordarizin-derivate
EA200100585A1 (ru) Применение производных фосфономуравьиной кислоты для лечения инфекций
RU2000123391A (ru) Производные триазола, обладающие противогрибковой активностью
CR7413A (es) R-(-)-1-[2-(7-Chlorobenzo[b]thiophen-3-yl-methozy)-2-(2,4-dichlorophenyl)-ethyl]-1H-imidazole